Mark Mossler - Chief Accounting Officer at C4 Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Accounting Officer
Stock Symbol
CCCC on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Mossler since 7/15/2023

Holdings reported by Mark Mossler for C4 Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 19.8 K $160 K $8.10 Feb 14, 2024 Direct
Stock Option (Right to Buy) 27.4 K Feb 14, 2024 Direct Common Stock

Transactions reported by Mark Mossler for C4 Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership